<DOC>
	<DOC>NCT02470286</DOC>
	<brief_summary>This study is a block-randomized, double-blind, placebo-controlled, single/multiple-dose, dose-escalation, Phase I clinical study to investigate the pharmacokinetics and safety/tolerability of SA001 in healthy male volunteer.</brief_summary>
	<brief_title>Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male Korean 1945 years Body weight:5590kg, BMI:18.027.0 Present condition or history of any clinically significant disease Clinical evidence or history of GI disease or history of GI surgery History of hypersensitivities, including drug allergies AST (SGOT) or ALT (SGPT) &gt; 1.5 times the upper normal limit eGFR &lt; 90mL/min/1.73m2 Systolic blood pressure : &lt;100 mmHg or &gt;160 mmHg Diastolic blood pressure : &lt;60 mmHg or &gt;100 mmHg QTcF &gt; 430msec (males) PR interval &gt; 200msec or &lt; 110msec Evidence of 2nd or 3rddegree atrioventricular (AV) block Pathologic Q waves (defined as Qwave &gt; 40msec or depth &gt; 0.5mV) Evidence of ventricular preexicitation, left bundle branch block (LBBB), right bundle branch block (RBBB, Incomplete RBBB) Family history of Long QT syndrome, sudden death or any risk factor of Torsade de pointes including heart failure, hypopotassemia, arrhythmia Drug abuse within 60 days, or a positive reaction to Drug testing in Urine Taken any ETC or herbal supplement within 14 days or any OTC or vitamin supplement within 7 days Participation in and administration of IP of another clinical trial within 90 days Donation of whole blood within 60 days, or blood components or receipt of blood transfusion within 30 days Consumption of more than 21 units of alcohol/week or inability to abstain from drinking during the study period Smoking within 90 days Taking caffeine or grapefruitcontaining products within 3 days Plan to be pregnant, or not to use an appropriate method of contraception</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>